Hidradenitis Supparativa Management: An Overview

Authors

  • Jessica Asgarpour, BSc., MD, FRCPC Clinical Associate, Women’s College Hospital, Toronto, ON

Abstract

Hidradenitis Suppurativa (HS) is a chronic debilitating inflammatory skin disease characterized by the formation of recurrent nodules, abscesses, sinus tracts, fistulas and scarring within apocrine gland‑bearing areas. HS affects up to 3.8% of the Canadian population with a higher prevalence among females. The condition is thought to be secondary to occlusion of the pilosebaceous unit and subsequent inflammation.

Author Biography

Jessica Asgarpour, BSc., MD, FRCPC, Clinical Associate, Women’s College Hospital, Toronto, ON

Dr. Jessica Asgarpour is a Canadian and American board‑certified dermatologist. She practices medical, surgical and cosmetic dermatology with a special interest in hidradenitis suppurativa, eczema, acne, psoriasis, and women’s health. She is currently working at Canadian Dermatology Centre and is also a clinical associate at Women’s College Hospital. She is an active sub-investigator for ongoing clinical trials.

References

Scuderi N, Monfrecola A, Dessy LA, Fabbrocini G, Megna M, Monfrecola G. Medical and surgical treatment of hidradenitis suppurativa: a review. Skin Appendage Disord. 2017;3(2):95-110. doi: 10.1159/000462979

Johnston LA, Alhusayen R, Bourcier M, Delorme I, George R, O’Brien E, et al. Practical guidelines for managing patients with hidradenitis suppurativa: an update. J Cutan Med Surg. 2022;26(2_suppl):2S-24S. doi: 10.1177/12034754221116115

Ocker L, Abu Rached N, Seifert C, Scheel C, Bechara FG. Current medical and surgical treatment of hidradenitis suppurativa-a comprehensive review. J Clin Med. 2022;11(23):7240. doi: 10.3390/jcm11237240

Shukla R, Karagaiah P, Patil A, Farnbach K, Ortega-Loayza AG, Tzellos T, et al. Surgical treatment in hidradenitis suppurativa. J Clin Med. 2022;11(9):2311. doi: 10.3390/jcm11092311

Hamzavi IH, Griffith JL, Riyaz F, Hessam S, Bechara FG. Laser and light-based treatment options for hidradenitis suppurativa. J Am Acad Dermatol. 2015;73(5 Suppl 1):S78-S81. doi: 10.1016/j.jaad.2015.07.050

Mukovozov I, Mirali S, Khaslavsky S, Kalia S. (2021). Light and laser-based treatments for hidradenitis suppurativa: a systematic review. SKIN The Journal of Cutaneous Medicine. 2021;5(6):601-620. doi: 10.25251/skin.5.6.4

Vu TT, Soong L. Prospective study of deroofing in the management of hidradenitis suppurativa. JAAD. 2022;87(3)Supplement, AB4. doi: 10.1016/j.jaad.2022.06.052

Mehdizadeh A, Hazen PG, Bechara FG, Zwingerman N, Moazenzadeh M, Bashash M, Sibbald RG, Alavi A. Recurrence of hidradenitis suppurativa after surgical management: A systematic review and meta-analysis. J Am Acad Dermatol. 2015 Nov;73

Published

2023-12-18

How to Cite

1.
Asgarpour J. Hidradenitis Supparativa Management: An Overview. Can Dermatol Today [Internet]. 2023 Dec. 18 [cited 2024 Nov. 21];4(4):5-8. Available from: https://canadiandermatologytoday.com/article/view/4-4-asgarpour

Issue

Section

Articles